-
RHEB Neddylation Drives mTORC1 in Liver Cancer
2026-09-21
The reference study identifies RHEB as a direct neddylation substrate of the UBE2F–SAG axis and shows that modification at K169 strengthens lysosomal localization and GTP binding, thereby activating mTORC1. Cell, mouse, and hepatocellular carcinoma evidence connects this mechanism with liver steatosis, tumorigenesis, and patient survival, while also defining experimental considerations for studying the pathway.
-
Bay 11-7821: IKK and NF-κB Research Guide
2026-09-21
Bay 11-7821, also called BAY 11-7082, is a reported IKK inhibitor that suppresses TNFα-linked NF-κB activation and supports mechanistic studies of inflammation, apoptosis, and cancer biology. Its reported 10 μM IC50, nonaqueous solubility, and cell- and model-specific evidence require careful dose, vehicle, and endpoint interpretation.
-
Bile Acid Retention Drives Immune Escape in MASH-HCC
2026-09-20
The reference study defines a GPR120–FXR–ABCB11–bile acid–NLRC5 pathway that connects lipid-associated metabolic stress with defective MHC-I antigen presentation in MASH-HCC. Its preclinical data indicate that restoring bile acid regulation with the FXR agonist Tropifexor can improve tumor immunogenicity and strengthen anti-PD-1 responses, while also identifying important questions for model transferability.
-
Vidarabine Monohydrate Antiviral Workflows
2026-09-19
Build more reliable antiviral experiments with Vidarabine monohydrate, a DMSO-soluble nucleoside analog suited to staged viral DNA synthesis and replication studies. This guide combines formulation controls, orthogonal readouts, and a carefully bounded assay-design lesson from a recent screening study.
-
Streptozotocin and PDN: From STZ to TBK1
2026-09-18
Streptozotocin (STZ) is more than a diabetes-induction reagent: it is an upstream perturbation that enables mechanistic studies of β-cell loss, neuropathy, and neuroinflammation. This article connects experimental diabetes mellitus induction with the TBK1–microglia pyroptosis pathway and practical assay design.
-
NP-40 Lysis Buffer for FPR2/ALX Signaling Assays
2026-09-18
Use a mild, non-denaturing extraction workflow to preserve phospho-SYK/AKT signals and native immune-cell protein complexes in FPR2/ALX studies. This guide translates the reference study into practical Western blot, immunoprecipitation, and co-immunoprecipitation workflows while addressing sample-specific lysis limitations.
-
S Tag Peptide: Workflow, QC, and Limitations
2026-09-17
S Tag Peptide supports recombinant protein workflows that require a compact, highly soluble sequence for antibody-based detection and construct-level solubility assessment. It is best used in aqueous expression and purification workflows with compatible anti-S-Tag reagents, not as an independently active enzyme or an ethanol-soluble reagent.
-
c-Myc Peptide: Assay Workflows and Optimization
2026-09-17
The c-Myc tag peptide provides a reversible, sequence-specific way to test anti-c-Myc antibody binding and displace tagged fusion proteins without relying only on harsh elution. This guide connects practical immunoassay controls with transcription-factor research, including experimental design, solubility handling, quantitative optimization, and troubleshooting.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-16
Carbenoxolone disodium is a research tool for perturbing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in controlled cell, tissue, and enzyme workflows. It is useful for mechanistic studies, but should not be treated as a selective target-validation reagent or a stand-alone in vivo efficacy compound.
-
RHEB Neddylation Activates mTORC1 in Liver Cancer
2026-09-16
The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation machinery and links modification at K169 to enhanced lysosomal localization, GTP binding, and mTORC1 activation. Genetic studies in cultured cells and a liver-specific Pten-loss model connect this mechanism to steatosis, tumorigenesis, and clinically relevant hepatocellular carcinoma survival associations.
-
SB 431542: From ALK5 Mechanism to Translation
2026-09-15
SB 431542 offers a precise way to interrogate ALK5-driven TGF-β biology while exposing the limits of receptor-level simplification. This thought-leadership guide connects Smad2 pathway analysis with glioma, immunology, and primary HLA-G-positive extravillous trophoblast models to help translational researchers design more interpretable studies.
-
Multiplex PBMC Flow Cytometry for Immunomodulator Screening
2026-09-15
Brox and Hackstein developed and validated a human PBMC-based multiplex flow cytometry assay that measures T-cell proliferation and activation together with B-cell costimulatory responses. Its defined stimulation conditions, multiparametric readouts, and Z-factor validation provide a practical framework for identifying subtle immunomodulatory effects in physiologically relevant primary cells.
-
7ACC2 and the Immunometabolic Lactate Axis
2026-09-14
Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, can clarify lactate transport, mitochondrial pyruvate handling, and radiosensitization. This article connects transport-focused cancer metabolism research with the CH25H–AMPKα–STAT6 macrophage pathway while emphasizing assay controls and interpretive limits.
-
Angiotensin II A1042: Practical Research Workflow
2026-09-14
Angiotensin II (SKU A1042) provides a defined octapeptide stimulus for receptor-linked vascular, hypertrophy, oxidative-stress, and remodeling assays. It is appropriate for controlled in vitro and animal-model research, but not for diagnostic, therapeutic, or clinical use; concentration, exposure time, receptor context, and vehicle should be validated for each system.
-
RHEB Neddylation Activates mTORC1 in Liver Cancer
2026-09-13
The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation machinery and maps the modification to lysine 169. By linking this modification to lysosomal RHEB localization, stronger GTP binding, mTORC1 activation, and PTEN-loss-driven liver tumorigenesis, the work expands the functional scope of neddylation beyond cullin regulation. Its combination of cellular, genetic, in vivo, and patient-correlation evidence provides a framework for studying this axis in liver disease.